News

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...
In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.
The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
The Democratic Republic of the Congo (DRC) is wrestling with a deepening health crisis as a cholera outbreak hit an “acute ...
Africa has recorded more than 4,200 deaths due to ongoing cholera and mpox outbreaks in different parts of the continent in ...
As part of its continued support to Sierra Leone’s health sector, the World Health Organization (WHO) has donated essential ...
The World Health Organization (WHO) has renewed its declaration that Mpox (formerly monkeypox) remains a Public Health Emergency of International Concern (PHEIC). WHO Director-General Dr. Tedros ...
The World Health Organization (WHO) has recommended the global use of injectable lenacapavir (LEN) twice a year to provide near-total ...
Cholera and mpox outbreaks have killed 4,200 people in different parts of Africa, the Africa Centers for Disease Control and ...
The risk of further mpox transmission is “high” within Africa and the risk of “international spread outside of Africa” is “moderate particularly through travel-linked transmission”, according to a ...